ArticleMolecular therapy. Methods & clinical development2024

Intrathecal or intravenous AAV9-IDUA/RGX-111 at minimal effective dose prevents cardiac, skeletal and neurologic manifestations of murine MPS I.

Lalitha R Belur et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.